Increased serum C-reactive protein is an adverse prognostic factor in low-risk myelodysplastic syndromes.
Baba Y, Saito B, Shimada S, Sasaki Y, Fujiwara S, Arai N, Kawaguchi Y, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Hattori N, Harada H, Nakamaki T.
Baba Y, et al. Among authors: hattori n.
Int J Hematol. 2021 Oct;114(4):441-448. doi: 10.1007/s12185-021-03187-7. Epub 2021 Jul 5.
Int J Hematol. 2021.
PMID: 34227058